As a Barclays analyst put it, it’s been a “slow-moving car crash”. Early supply shortages pushed patients to competitors, while Novo’s cautious marketing lagged behind Lilly’s aggressive, ...

Denmark’s status as one of the few countries in Europe with an expanding economy rests in part on the success of its ...

Trade deficit data, Federal Reserve officials' remarks, earnings from Pfizer, Disney, Uber, and additional companies.

It's been a wild first half of the year for stocks in 2025, but finding the right companies for your portfolio is a very ...

Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS ...

When it was riding high, Novo Nordisk could have done M&A to reduce its dependence on obesity treatments. It didn’t.

Most major stock indexes across the globe ended the week lower over tariff jitters, while the focus also remained on ...